Individual and joint effects of metformin and statins on mortality among patients with high ‐risk prostate cancer

ConclusionsStatin use alone or in combination with metformin was associated with lower all ‐cause and PCa mortality among high‐risk patients, particularly in post‐diagnostic settings; further studies are warranted.

Source: Cancer Medicine - February 11, 2020 Category: Cancer & Oncology Authors: Xiang ‐Lin Tan, Jian‐Yu E, Yong Lin, Timothy R. Rebbeck, Shou‐En Lu, Mingyi Shang, William K. Kelly, Anthony D'Amico, Mark N. Stein, Lanjing Zhang, Thomas L. Jang, Isaac Yi Kim, Kitaw Demissie, Anna Ferrari, Grace Lu‐Yao Tags: ORIGINAL RESEARCH Source Type: research